
Mazindol - Wikipedia
Mazindol, sold under the brand names Mazanor and Sanorex, is a central nervous system (CNS) stimulant which is used as an appetite suppressant. [2] It was developed by Sandoz-Wander …
Mazindol Uses, Side Effects & Warnings - Drugs.com
Mazindol stimulates the central nervous system (nerves and brain), which increases your heart rate and blood pressure and decreases your appetite. Mazindol is used as a short-term …
Mazindol: Uses, Interactions, Mechanism of Action - DrugBank …
2005年6月13日 · Mazindol is a tricyclic anorexigenic agent that is unrelated to and less toxic than amphetamine, but with some similar side effects. It inhibits uptake of catecholamines and …
Mazindol Side Effects: Common, Severe, Long Term - Drugs.com
If you experience any of the following serious side effects, stop taking mazindol and seek emergency medical attention: an allergic reaction (difficulty breathing; closing of your throat; …
Mazindol ¿Qué es y Para qué Sirve? Dosis - QuéFarmacia
2022年12月12日 · Mazindol es un medicamento anorexígeno, que se usa como complemento de la dieta y el ejercicio a corto plazo para disminuir el apetito y así facilitar la pérdida de peso. …
Mazindol - an overview | ScienceDirect Topics
Mazindol (Teronac®) is an imidazoline derivative which blocks dopamine and norepinephrine reuptake and is active against EDS and cataplexy. From: Handbook of Clinical Neurology, 2013
Phase 3 Trial of Mazindol ER for Narcolepsy to Begin
2023年7月6日 · The AMAZE program will encompass two almost-identical double-blind phase 3 studies (N=50 each) investigating mazindol ER versus placebo in adult patients with …
Mazindol | C16H13ClN2O | CID 4020 - PubChem
It is a Stimulants substance. Mazindol is a tricyclic anorexigenic agent that is unrelated to and less toxic than [amphetamine], but with some similar side effects. It inhibits uptake of …
Mazindol Demonstrates Safety Profile in Narcolepsy Treatment
2023年6月15日 · Mazindol is a triple monoamine reuptake inhibitor and partial orexin-2 receptor agonist, which was used for many years to treat patients diagnosed with narcolepsy in …
MAZINDOL - National Center for Advancing Translational Sciences
Mazindol is an amphetamine-like medicine which was developed by Sandoz in 1967 and approved by FDA for the treatment of obesity and Duchenne muscular dystrophy under the …
- 某些结果已被删除